Cargando…

Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension

BACKGROUND: Hypertension is a global public health crisis. Poorly controlled high blood pressure is one of the major factors contributed to this crisis. As lack of treatment adherence is often considered the main reason for this failure, the Treatment Adherence Questionnaire for Patient with Hyperte...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehghan, Mahlagha, Dehghan-Nayeri, Nahid, Iranmanesh, Sedigheh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933746/
https://www.ncbi.nlm.nih.gov/pubmed/27429627
_version_ 1782441219968729088
author Dehghan, Mahlagha
Dehghan-Nayeri, Nahid
Iranmanesh, Sedigheh
author_facet Dehghan, Mahlagha
Dehghan-Nayeri, Nahid
Iranmanesh, Sedigheh
author_sort Dehghan, Mahlagha
collection PubMed
description BACKGROUND: Hypertension is a global public health crisis. Poorly controlled high blood pressure is one of the major factors contributed to this crisis. As lack of treatment adherence is often considered the main reason for this failure, the Treatment Adherence Questionnaire for Patient with Hypertension (TAQPH) was developed. Since this questionnaire should be reliable and strongly valid to be used in clinics and research, this study was performed to test the reliability and validity of the TAQPH. METHODS: A cross-sectional study was conducted to validate the Persian version of TAQPH after using a modified forward/backward translation procedure. A total of 330 hypertensive patients were participated in this study. Construct and criterion validity, Cronbach¢s alpha, and test-retest reliability were used to validate the Persian scale. RESULTS: Data analysis showed that the scale had excellent stability (intraclass correlation = 0.95) and good acceptability of internal consistency (α = 0.80). The exploratory factor analysis (EFA) was meaningful but was not confirmed with confirmatory factor analysis (CFA). The scale score was correlated with Morisky Medication Adherence Scale (MMAS) score (Ρ = 0.27). CONCLUSION: In total, most of the psychometric properties of the 25-item P-TAQHP achieved the standard level and were sufficient to recommend for general use.
format Online
Article
Text
id pubmed-4933746
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-49337462016-07-15 Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension Dehghan, Mahlagha Dehghan-Nayeri, Nahid Iranmanesh, Sedigheh ARYA Atheroscler Original Article BACKGROUND: Hypertension is a global public health crisis. Poorly controlled high blood pressure is one of the major factors contributed to this crisis. As lack of treatment adherence is often considered the main reason for this failure, the Treatment Adherence Questionnaire for Patient with Hypertension (TAQPH) was developed. Since this questionnaire should be reliable and strongly valid to be used in clinics and research, this study was performed to test the reliability and validity of the TAQPH. METHODS: A cross-sectional study was conducted to validate the Persian version of TAQPH after using a modified forward/backward translation procedure. A total of 330 hypertensive patients were participated in this study. Construct and criterion validity, Cronbach¢s alpha, and test-retest reliability were used to validate the Persian scale. RESULTS: Data analysis showed that the scale had excellent stability (intraclass correlation = 0.95) and good acceptability of internal consistency (α = 0.80). The exploratory factor analysis (EFA) was meaningful but was not confirmed with confirmatory factor analysis (CFA). The scale score was correlated with Morisky Medication Adherence Scale (MMAS) score (Ρ = 0.27). CONCLUSION: In total, most of the psychometric properties of the 25-item P-TAQHP achieved the standard level and were sufficient to recommend for general use. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2016-03 /pmc/articles/PMC4933746/ /pubmed/27429627 Text en © 2016 Isfahan Cardiovascular Research Center & Isfahan University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Dehghan, Mahlagha
Dehghan-Nayeri, Nahid
Iranmanesh, Sedigheh
Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension
title Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension
title_full Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension
title_fullStr Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension
title_full_unstemmed Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension
title_short Translation and validation of the Persian version of the treatment adherence questionnaire for patients with hypertension
title_sort translation and validation of the persian version of the treatment adherence questionnaire for patients with hypertension
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933746/
https://www.ncbi.nlm.nih.gov/pubmed/27429627
work_keys_str_mv AT dehghanmahlagha translationandvalidationofthepersianversionofthetreatmentadherencequestionnaireforpatientswithhypertension
AT dehghannayerinahid translationandvalidationofthepersianversionofthetreatmentadherencequestionnaireforpatientswithhypertension
AT iranmaneshsedigheh translationandvalidationofthepersianversionofthetreatmentadherencequestionnaireforpatientswithhypertension